Why the study?
Does orthotopic cardiac transplantation improve survival and rehabilitation in patients with inoperable end-stage heart disease?
Does orthotopic cardiac transplantation improve survival and rehabilitation in patients with inoperable end-stage heart disease?
Orthotopic cardiac transplantation is a viable therapeutic option for inoperable end-stage heart disease, offering good survival and high rehabilitation potential.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for cardiac transplantation in end-stage disease; prospective trials needed before adoption.
Based on the Stanford series of 188 patients, we emphasize that orthotopic cardiac transplantation represents a reasonable therapeutic option for the patient with inoperable end-stage heart disease. Current expectations for survival equal those for organ survival in cadaver renal transplant series and offer a rehabilitation potential of over 90%. Most of the complications limiting survival are due to the currently available means of immunosuppression and, therefore, advances in the field of immunosuppression can be expected to have a major positive influence on survival rates.
No takes yet. Share an insight, caveat, or question.
Hunt et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: